Drug profile · INN
cefoxitin sodium
MEFOXIN
cefoxitin sodium (MEFOXIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefoxitin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefoxitin sodium (MEFOXIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefoxitin sodium?
cefoxitin sodium (MEFOXIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefoxitin sodium?
MEFOXIN is a marketed brand name for cefoxitin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefoxitin sodium?
cefoxitin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.